Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reza J Mehran

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Cancer|July 10, 2019
Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised miceYungchang Chen, Ran Zhang, Li Wang, et al.
Nature Medicine|September 8, 2025
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analysesJoshua E Reuss, Paul K Lee, Reza J Mehran, et al.
Human Pathology|August 31, 2017
Thymoma: a clinicopathological correlation of 1470 casesAnnikka Weissferdt, Neda Kalhor, Justin A Bishop, et al.
The Lancet. Oncology|May 19, 2015
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsJoe Y Chang, Suresh Senan, Marinus A Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2020
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal CancerSteven H Lin, Brian P Hobbs, Vivek Verma, et al.
Lancet (London, England)|July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trialJoe Y Chang, Steven H Lin, Wenli Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2020
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung CancerTina Cascone, Boris Sepesi, Heather Y Lin, et al.
Annals of Surgical Oncology|March 18, 2026
ASO Visual Abstract: Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-SurgKoichi Tomita, Paula M Smith, Maho Takayama, et al.
Annals of Surgical Oncology|February 19, 2026
Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-SurgKoichi Tomita, Paula M Smith, Maho Takayama, et al.
Journal for Immunotherapy of Cancer|October 24, 2024
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancerNicolas Zhou, Cheuk H Leung, William N William, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Cancer|July 10, 2019
Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised miceYungchang Chen, Ran Zhang, Li Wang, et al.
Nature Medicine|September 8, 2025
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analysesJoshua E Reuss, Paul K Lee, Reza J Mehran, et al.
Human Pathology|August 31, 2017
Thymoma: a clinicopathological correlation of 1470 casesAnnikka Weissferdt, Neda Kalhor, Justin A Bishop, et al.
The Lancet. Oncology|May 19, 2015
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsJoe Y Chang, Suresh Senan, Marinus A Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2020
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal CancerSteven H Lin, Brian P Hobbs, Vivek Verma, et al.
Lancet (London, England)|July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trialJoe Y Chang, Steven H Lin, Wenli Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2020
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung CancerTina Cascone, Boris Sepesi, Heather Y Lin, et al.
Annals of Surgical Oncology|March 18, 2026
ASO Visual Abstract: Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-SurgKoichi Tomita, Paula M Smith, Maho Takayama, et al.
Annals of Surgical Oncology|February 19, 2026
Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-SurgKoichi Tomita, Paula M Smith, Maho Takayama, et al.
Journal for Immunotherapy of Cancer|October 24, 2024
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancerNicolas Zhou, Cheuk H Leung, William N William, et al.
Pageof 20